WALLY JOSEPH: Open Payments
NPI 1326595125 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 86 payments from 16 companies in 2025. Trend: 2023 $678 · 2024 $1,259 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 21 | $354 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $256 |
| Janssen Pharmaceuticals, Inc | 5 | $196 |
| Braeburn Inc. | 7 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $101 |
| ABBVIE INC. | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Exact Sciences Corporation | 4 | $63 |
| Lundbeck LLC | 4 | $61 |
| Indivior Inc. | 2 | $59 |
Products named: REXULTI, CAPLYTA, INVEGA SUSTENNA, BRIXADI, TRINTELLIX, ABILIFY ASIMTUFII, VRAYLAR, Auvelity.
Industry payments across NV — which companies pay providers there.
